| Bioactivity | Metrizamide (Amipaque) is used as the contrast medium for angiography in neuroradiological investigations[1]. Metrizamide inhibits human brain hexokinase[2]. | |||||||||
| Invitro | Metrizamide is a contrast medium possessing unique properties, one of which is that even in an isotonic solution it has a radiographic density sufficient for a diagnostic myelogram[3]. | |||||||||
| Name | Metrizamide | |||||||||
| CAS | 31112-62-6 | |||||||||
| Formula | C18H22I3N3O8 | |||||||||
| Molar Mass | 789.10 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Vogelsang H, et al. Zerebrale und spinale Angiographie mit Metrizamid (Amipaque) [Cerebral and spinal angiography with metrizamide (amipaque) (author's transl)]. Rofo. 1978;129(5):559-561. [2]. Bertoni JM. Metrizamide inhibits human brain hexokinase. Neurology. 1982;32(8):884-887. [3]. Funkquist B. Myelographic localization of spinal cord compression in dogs. A comparison between cisternal and lumbar injections of metrizamide "Amipaque" in diagnosing and locating spinal cord compression. Acta Vet Scand. 1975;16(2):269-287. |
Metrizamide
CAS: 31112-62-6 F: C18H22I3N3O8 W: 789.10
Metrizamide (Amipaque) is used as the contrast medium for angiography in neuroradiological investigations.Metrizamide in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.